Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Resolution Revolution

Resolution Revolution
OUR SCIENCE/ Resolution Revolution
December 19, 2017

Image of a ribosome — the part of the cell where proteins are synthesized — captured with a cryo-electron microscope at Pfizer's Groton, Connecticut, site. Cryo-EM can achieve a resolution of about 3 angstroms — three-tenths of a nanometer.

By Paul Shin, original article from Get Science.

The history of microscopes is one of ever higher magnification, enabling scientists to peer deeper and deeper into the minute details of nature invisible to the naked eye.

The latest category of this powerful tool is what's called a cryo-electron microscope, and its groundbreaking properties are revolutionizing the way scientists are imaging the smallest of structures — especially in the life sciences.

The cryo-electron microscope, or cryo-EM, is allowing scientists to image structures as small as viruses and ribosomes — the part of the cell where proteins are synthesized. More importantly, it does this without the need to turn the samples into crystals — the often tricky step needed when using X-ray crystallography, which has until recently been the go-to technology when imaging microscopic structures.

"We call it a resolution revolution," says Seungil Han, Associate Research Fellow at Pfizer's Groton, Connecticut, site, which is currently home to the only fully operational Titan Krios microscope in the world outside of academia. It began operating in October 2016.

"The requirement of X-ray crystallography is that you need to obtain a diffracting crystal to get atomic resolution. That has been a big hurdle if you're working on challenging targets," Han says, referring to certain irregular proteins that can be incredibly difficult to crystallize. "Almost every target we're working on now is very challenging."

With cryo-EM, you don't need the sample to be in crystal form, and you can still achieve a resolution of about 3 angstroms — three-tenths of a nanometer. A chlorine atom, for example, has a radius of about 1 angstrom.

Why Electron Beams Are Used Instead of Light to See the Truly Tiny

The theoretical limit of resolution of an optical microscope is on the order of the wavelength of the light that is used. Since visible light has a wavelength of about 4,000 to 7,000 angstroms, an optical microscope — even under ideal conditions — can't reveal structures much smaller than that.

However, when you use a beam of electrons as the source of "light" — as is done with transmission electron microscopes — you can achieve resolutions on the order of 1 angstrom.

Putting the Cryo in Electron Microscopes

Shooting a beam of high-energy electrons onto a sample is fine if it's an inert object, but when the target is biological, like a fragile protein, that's a recipe for damage.

"If you shoot a high dose of electrons, you will pretty much fry a biological sample," Han explains, noting that's one reason why the target is frozen to liquid nitrogen temperatures. That's where the cryo-EM gets the "cryo" part of its name.

cryo-em_940px.jpg

Pfizer's Groton, Connecticut, site, is currently home to the only fully operational Titan Krios cryo-electron microscope in the world outside of academia. It began operating in October 2016.

The cryo-EM at Pfizer's Groton site is a hulking structure about the size of a large van that sits in a darkened, temperature-controlled room. Once a sample is loaded into the microscope, the machine can operate autonomously for a few days, spitting out image files that are 2 to 3 terabytes in size — the equivalent of thousands of high-definition movies.

To process that huge amount of image data, Han and his team employ a computer with powerful graphical processing units developed in the video gaming business.

"If your processing capabilities are too slow, you can't keep up with the data," Han says, noting that advances in computer hardware and programming were integral in making cryo-EM viable as much as the detector itself.

And because the cryo-EM can create 3-D images, or even "movies," a cryo-EM image of the same resolution as an X-ray crystallography image is more useful, says Han, a biochemist who was trained as an X-ray crystallographer.

"We've already gotten some atomic structures since the grand opening, and we're quite excited about it," Han says.

If there is a bottleneck to the growth of cryo-EM, it hasn't been the technology, but rather the difficulty in recruiting researchers trained in the field, Han says. "It's a hot new field."

How Cryo-EM Imaging Can Help Scientists

It's one thing to know the structure of a protein. But how does that help scientists, for example, create better medicines?

In the case of the ribosome — the cell's protein factory — a high-resolution image can take the guessing game out of drug design, Han says. "We can find the compound binding site, see how it interacts and improve the potency."

cryo_em_open940px.jpg

Pfizer's Groton, Connecticut, site, is currently home to the only fully operational Titan Krios cryo-electron microscope in the world outside of academia. It began operating in October 2016.

Cryo-EM could also help scientists create better vaccines, such as the RSV vaccine, which is given to women to protect their babies from the respiratory syncytial virus (RSV), Han says as he points to a poster of the triangular shaped virus successfully imaged in his lab recently.

"We're really keen on making an impact using this technology," Han says.

Related Hot Topics
pfizer_get-science_smc_korean-breast-cancer_300x170.jpg
Using ‘Omics to Understand the Rise in Breast Cancers Among Young Asians
cancer_and_enzymes_300x170.jpg
Attacking Cancer Cells That Develop Resistance
sharon_campbell300x170.jpg
An Inside Look at Pfizer’s Postdoc Program With Our Own Sharon Campbell
Breaking the Rules of Biology to Beat Rare Genetic Disease
new_rna_technology300x170.jpg
New RNA Technology Could Get the Flu Vaccine Right, Every Year
Media Name: manoj_charati300x170.jpg
This Scientist’s Life: Manoj Charati
Media Name: pfizer_get-science_red-vapor_bioduro_300x170.jpg
Using the Dr. Jekyll of Chemical Compounds to Advance Drug Synthesis
Media Name: cyclin-dependent_kinase_inhibitor_complex_1000x450.jpg
There’s No ‘I’ in Drug Development
Tags
Get Science
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.